NCT00671515: Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome |
|
|
| Completed | 2 | 23 | US | Pioglitazone, Actos | Joseph Calabrese, MD, Takeda Pharmaceuticals North America, Inc. | Depressive Disorder, Major, Metabolic Syndrome X | 08/11 | 11/11 | | |